期刊文献+

血清巨噬细胞移动抑制因子对严重脓毒症患者心肌抑制的预后价值

Predictive value of serum macrophage migration inhibitory factor for myocardial depression in severe sepsis patients
原文传递
导出
摘要 目的 探讨血清巨噬细胞移动抑制因子(MIF)对严重脓毒症患者心肌抑制的预后价值.方法 采用前瞻性研究方法,对符合严重脓毒症诊断标准的42例患者进行研究,入住ICU当天知情同意后行PICCO监测,并给予相应治疗.入住当天根据血流动力学分为两组,心脏指数<3 L/(min/m2)并且全心舒张末期容积指数>800 ml/m2为心肌抑制组,其余为非心肌抑制组.根据28 d生存情况分为生存组和死亡组.入住第1,3,5天收集血流动力学指标及血清MIF、B型钠尿肽(BNP)、心肌肌钙蛋白I(cTnI)水平.结果 42例严重脓毒症患者中,未发生心肌抑制22例(非心肌抑制组),发生心肌抑制20例(心肌抑制组);28 d时,生存20例(生存组),死亡22例(死亡组).死亡组第1,3,5天血清MIF均高于生存组,差异有统计学意义(P<0.01);两组第1天BNP、cTnI比较差异无统计学意义(P>0.05),死亡组第3,5天BNP、cTnI均高于生存组,差异有统计学意义(P<0.01).心肌抑制组各时间点血清MIF水平均明显高于非心肌抑制组[生存:8.70(3.53,16.80) μg/L比1.20(0.80,1.77) μg/L、2.30(1.33,8.40) μg/L比0.60(0.60,0.99) μg/L、0.50(0.31,2.50) μg/L比0.16(0.15,0.20) μg/L,死亡:11.43(8.10,17.16)μg/L比2.30(1.96,3.69) μg/L、9.70(6.55,14.65)μg/L比1.90(1.88,5.27) μg/L、7.50(5.15,14.20) μg/L比2.40(0.80,8.46) μg/L],差异有统计学意义(P<0.05);且两组死亡患者血清MIF水平均高于生存患者,差异有统计学意义(P<0.05).第5天MIF具有最大预测价值,曲线下面积为0.952,当其截断点为0.65 μg/L时,其灵敏度为100%(22/22),特异度为85%(17/20).多因素Logistic回归分析结果显示,仅APACHEⅡ评分是28 d病死率的独立危险因素(P<0.01),而MIF不能独立预测28d病死率(P>0.05).结论 血清MIF水平升高提示严重脓毒症患者预后差,动态监测血清MIF变化有助于评估严重脓毒症患者心肌抑制的预后和严重程度,但MIF不是预测28 d病死率的独立危险因素. Objective To evaluate the predictive value of serum macrophage migration inhibitory factor (MIF) for myocardial depression in severe sepsis patients.Methods Taken prospective study method,42 cases of severe sepsis patients were enrolled from December 2011 to June 2013.The patients were monitored by PICCO system after informing consent into ICU day,and given the corresponding treatment.According to the hemodynamic parameters were divided into two groups,myocardial depression group:cardiac index 〈 3 L/(min· m2) and global end diastolic volume index 〉 800 ml/m2,the remaining were in non myocardial depression group,and the patients were divided into survival group and death group according to 28-d mortality.Hemodynamic parameters and serum MIF,B-type natriuretic peptide (BNP),cardiac troponin Ⅰ (cTnI) level at the 1st,3rd,Sth day after admission.Results Fortty-two severe sepsis patients,non myocardial depression in 22 cases (non myocardial depression group),myocardial suppression in 20 cases (myocardial depression group).At 28 d,20 patients of survival (survival group),22 patients of death (death group).The serum MIF in death group was higher than that in survival group at the 1st,3rd,5th day (P 〈 0.01) ; BNP and cTnI at the 1st day in two groups had no statistical significance (P 〉0.05),BNP and cTnI at the 3rd,5th day in death group was higher than that in survival group(P 〈 0.01).The serum MIF at each time point in myocardial depression group was higher than that in non myocardial depression group [survival:8.70(3.53,16.80) μ g/L vs.1.20(0.80,1.77) μ g/L,2.30(1.33,8.40) μ g/L vs.0.60 (0.60,0.99) μg/L,0.50 (0.31,2.50) μg/Lvs.0.16 (0.15,0.20) μg/L;death:11.43(8.10,17.16) μ g/L vs.2.30(1.96,3.69) μ g/L,9.70(6.55,14.65) μ g/L vs.1.90(1.88,5.27) μ g/L,7.50(5.15,14.20)μ g/L vs.2.40(0.80,8.46) μ g/L] (P 〈 0.05).The serum MIF of death patients in two groups was higher than that of survival patients (P 〈 0.05).MIF at the 5th day had biggest prediction value,AUC was 0.952,when the cut-off point of 0.65 μg/L,the sensitivity was 100% (22/22) and specificity was 85% (17/20).Multivariable Logistic regression analysis results showed that only APACHE Ⅱ scores was the independent risk factor for 28-d mortality (P 〈 0.01),while MIF couldn' t independent forecast 28-d mortality (P 〉 0.05).Conclusions Elevation of serum MIF prompts severe sepsis patient with poor outcome,and dynamic changes of MIF is helpful to evaluate the prognosis and severity of severe sepsis patients with myocardial depression,but MIF is not an independent risk factor for predicting 28-d mortality.
出处 《中国医师进修杂志》 2014年第6期7-11,共5页 Chinese Journal of Postgraduates of Medicine
基金 天津医科大学第二医院科研基金(y1103)
关键词 脓毒症 心钠素 预后 心功能不全 Sepsis Atrial natriuretic factor Prognosis Myocardial dysfunction
  • 相关文献

参考文献13

  • 1Jozwiak M,Persicbini R,Monnet X,et al. Management of myocardial dysfunction in severe sepsis [J]. Semin Respir Crit Care Med, 2011,32(2) :206-214.
  • 2Levy MM,Fink MP,Marshall JC,et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [J]. Crit Care Med, 2003,31 (4) : 1250-1256.
  • 3Dellinger RP,Levy MM,Carlet JM,et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock:2008 [J]. Intensive Care Med,2008,34 (1):17-60.
  • 4Romero-Bermejo FJ, Ruiz-Bailen M,Gil-Cebrian J,et al. Sepsis- induced cardiomyopathy [ J ]. Curr Cardiol Rev, 2011,7 ( 3 ) : 163- 183.
  • 5李振华,董磊,王国兴,谢苗荣.脑利钠肽、肌钙蛋白T和I监测对重症脓毒症和脓毒症休克预后的意义[J].中华急诊医学杂志,2012,21(9):1016-1021. 被引量:53
  • 6陈国锋,李子龙,徐杰丰,高金丹.脓毒症患者血浆氨基末端脑利钠肽前体及肌钙蛋白I测定的价值[J].中华急诊医学杂志,2011,20(3):253-254. 被引量:14
  • 7Grieb G,Merk M,Bernhagen J,et al. Macrophage migration inhibitory factor (MIF) :a promising biomarker [J]. Drug News Perspect,2010,23(4) :257-264.
  • 8Chagnon F,Metz CN,Bucala R,et al. Endotoxin-induced myocardial dysfunction : effects of macrophage migration inhibitory factor neutralization[J]. Circ Res, 2005,96(10) : 1095-1102.
  • 9Flied MA, Rittirsch D, Huber-Lang MS, et al. Molecular events in the cardiomyopathy of sepsis [J]. Mol Med,2008,14 (5/6) :327- 336.
  • 10刘健,王洪霞,门昆.血清N末端脑钠肽前体水平与脓毒症预后的关系[J].中国危重病急救医学,2012,24(11):662-664. 被引量:27

二级参考文献90

  • 1汪芳,王莉,边文彦,顼志敏,李一石.慢性心力衰竭急性发作患者N端前脑钠素水平的变化[J].中国危重病急救医学,2006,18(4):195-198. 被引量:21
  • 2王国兴,沈潞华,郝国栋,谢苗荣,金明,张淑文.芪参活血颗粒对脓毒症大鼠心肌保护作用的研究[J].中国现代医学杂志,2006,16(22):3404-3408. 被引量:9
  • 3成人严重感染与感染性休克血流动力学监测与支持指南[J].中华急诊医学杂志,2007,16(2):121-126. 被引量:70
  • 4Metha NJ, Khan IA, Gupta V, et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock [ J ]. Int J Cardiol, 2004,95 ( 1 ) : 13-17.
  • 5Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syn- dromes[J]. J Am Coll Cardiol, 2003,41 ( 11 ) :2004-2009.
  • 6Januzzi JL, Morss A, Tung R, et al. Natriuretie peptide testing for the evaluation of critically ill patients with shock in the intensive care unit:a prospective cohort study[J]. Crit Care, 2006,10(2) :134.
  • 7Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology ofsevere sepsis in the United States:analysis of incidence, outcome,and associated costs of care [ J ]. Cnt Care Med, 2001,29 (7) :1303-1310.
  • 8Gorissen C, Baumgarten R, de Gtoot M, et al. Analytical and clini-cal performance of three natriuretic peptide tests in the emergencydepartment room[ J ]. Clin Chem Lab Med, 2007,45 (5) :678-684.
  • 9Varpula M, Pulkki K, Karlsson S, et al. Predictive valve of N-tem-inal pro-brain natriuretic peptide in severe sepsis and septic shock[J] . Crit Care Med, 2007,35(5):1277-1283.
  • 10Ammann P, Fehr T, Minder El, et al. Elevation of troponin I in sep-sis and septic shock[J]. Intens Care Med, 2001,27(6) :965-969.

共引文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部